# Effects of Ulinastatin on Inflammatory Response During ECMO Support

> **NCT04990752** · — · UNKNOWN · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 144 (estimated)

## Conditions studied

- ECMO
- Inflammatory Response

## Interventions

- **DRUG:** ulinastatin

## Key facts

- **NCT ID:** NCT04990752
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-26
- **Primary completion:** 2023-03-01
- **Final completion:** 2023-06-01
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2021-08-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04990752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04990752, "Effects of Ulinastatin on Inflammatory Response During ECMO Support". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04990752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*